Articles tagged with Drug Therapy
A new study found that continuing checkpoint inhibitor treatment after tumor growth can significantly extend survival for some head and neck cancer patients. The research, based on a phase 3 clinical trial, showed that 57 of 139 patients who continued treatment had a median survival period of 12.7 months.
The US Preventive Services Task Force found inadequate evidence on celiac disease screening accuracy, benefits and harms of screening, and treatment effects. Current evidence is insufficient to assess balance of benefits and harms of screening for asymptomatic individuals.
Researchers have discovered small molecule drugs that activate signaling pathways leading to specific adult brain cell types from stem cells. These findings provide new insights into neural development and repair, identifying several new approved drugs with potential therapeutic value for brain injury repair.
Researchers developed minitablets with synthetic flavourings and coatings to enhance palatability, making it easier for cats to take medication. The study found that amino acids and vitamin B-based flavours were promising options, but further research is needed.
Research reveals that expression levels of ABCB1 and ABCG2 transporters significantly affect cell resistance to Dasatinib. Lower transporter expression levels mediate lower resistance, implying a potential breakthrough for targeted cancer treatment.
Smokers in recovery from illicit drug use disorders face a higher risk of relapsing three years later compared to non-smokers. Quitting cigarettes may help adults stay sober and improve substance treatment outcomes.
A University of Liverpool-led trial has successfully used nanotechnology to improve drug therapies for HIV patients, achieving a 50% dose reduction while maintaining therapeutic exposure. The trial's results have the potential to revolutionize HIV treatment, making it safer, more affordable and accessible to resource-limited countries.
A study found that minority groups, women, and residents of the 'Stroke Belt' are less likely to receive tissue plasminogen activator (tPA) treatment for ischemic stroke. Despite efforts to increase access, disparities persist in healthcare delivery.
A new clinical practice guideline provides comprehensive analysis of individual agents used in treating chronic insomnia disorder. The guideline recommends specific medications for sleep onset and maintenance insomnia, emphasizing the importance of sound clinical judgment in patient care.
Sandra Horning, a cancer survivor and renowned oncologist, will receive the Duane Roth Memorial Award for her pioneering work in developing new treatments for lymphoma. Her commitment to personalized therapies and holistic approaches to patient care has improved cancer treatment outcomes.
Researchers identify factors determining when containment or aggressive treatment is best, providing new guidance for physicians and patients. Containment strategies can prolong treatment life and improve outcomes in certain situations.
A new mathematical analysis provides guidance for treating infections and tumors with drug resistance, suggesting that containment may extend effective life and improve patient outcomes in some cases. The study identifies two main factors influencing the choice between containment and aggressive treatment.
Older adults with newly diagnosed epilepsy are often prescribed older anti-epileptic drugs, with only half starting treatment within the first 30 days. Despite this, minority groups do not appear to receive different AED treatment compared to whites.
Researchers at Washington State University found that offering prizes can be an effective, low-cost treatment for alcohol abuse among individuals with serious mental illness, reducing tobacco and drug use. The study's findings could expand treatment options for millions of Americans, particularly those from native populations.
Researchers at the University of Cincinnati are developing a cell therapy that utilizes modified facial muscle cells to regenerate heart tissue. This innovative approach aims to address the limitations of existing treatments, which often rely on drug therapies or surgery, and may reduce rejection risks.
Dr. Stanley T. Crooke presents a detailed look at the mechanisms underlying antisense drug activity, including prehybridization, hybridization, and post-hybridization phases. He highlights his group's contributions to characterizing ASO therapeutics' design, targeting, and mechanism of action.
Researchers are studying the effectiveness of two treatment options for children with Kawasaki disease who resist initial therapy. The study aims to compare the impact of IVIG and infliximab on preventing heart damage in these patients.
The IOF-ECTS Position Paper proposes measuring specific bone turnover markers to detect low adherence to oral bisphosphonates, a common issue in chronic diseases. This early identification enables discussion and intervention with patients, potentially improving treatment efficacy.
Researchers demonstrate that massaging hair can increase the delivery of nanoparticles to hair follicles by creating channels for particle transport. The ratchet mechanism enhances particle speed and diffusion when massaged parallel to the resting surface.
Terrie E. Taylor, a Michigan State University professor, is working on developing new treatments for cerebral malaria, the deadliest form of the disease. Her research aims to identify interventions that can reduce brain swelling and save children's lives.
The US Preventive Services Task Force concludes that screening for obstructive sleep apnea (OSA) in asymptomatic adults lacks sufficient evidence to assess benefits and harms. Current evidence supports treatment with CPAP, but its applicability to screen-detected populations is unknown.
Researchers have made significant progress treating anti-NMDA receptor encephalitis with a new regimen, including patients who previously did not respond. The treatment, which includes bortezomib, has shown to quickly improve clinical symptoms and reduce antibodies responsible for the disease.
A German multicenter study confirms the efficacy and safety of Lu-177-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer, demonstrating a positive response rate of 45% and manageable side effects. The treatment offers an additional option for end-stage patients with high response rates and low toxicity.
Hemodialysis patients have altered blood clots that increase cardiovascular and other cause mortality risks. Dense blood clots found in kidney failure patients also affect fibrinogen protein modifications.
Researchers at the University of Rochester Medical Center have identified a potential new treatment approach for lysosomal storage disorders, which cause disruptions in cellular functioning. The study found that repurposed drugs can overcome toxic build-up in affected cells, improving survival rates and quality of life.
A study of over 5,500 women found that younger patients and those who had taken hormone replacement therapy were less likely to adhere to their medicine. The researchers identified several factors that contributed to non-adherence, including socioeconomic status and marital status, highlighting the need for targeted strategies to impro...
A University of Liverpool study found that reducing the dose of leukemia drug tyrosine kinase inhibitors (TKI) can safely reduce side effects in patients with chronic myeloid leukemia. Patients who achieved stable molecular remission levels showed no evidence of leukaemia rebound after cutting their TKI dose, with some reporting signif...
Research shows that ibrutinib can benefit patients with GVHD who don't respond to corticosteroid treatment, with 71% experiencing sustained improvements. Ibrutinib targets specific immune cells involved in GVHD, offering a new therapeutic option for those with limited treatment options.
A recent randomized controlled trial found that high-dose baclofen added little to the effect of psychosocial treatment in patients with alcohol dependence. The study, involving 151 patients, showed no significant differences in relapse rates between groups receiving different doses of baclofen or placebo.
A panel of concussion experts recommends a more active approach to treatment, matching treatments to specific symptoms and impairments. The 'TEAM' approach aims to enhance recovery by targeting individual clinical profiles and using multidisciplinary rehabilitation teams.
A study published in BMJ Open found that many fertility clinics make unsubstantiated claims about treatments beyond standard IVF procedures. The researchers identified a lack of supporting evidence cited by websites and clinics, with only a few interventions having moderate quality evidence to support their benefits.
Research at RIT aims to understand vitreous humor properties that result in vision impairment. The study may unlock new treatments for vision disorders and improve drug delivery and eye surgery.
A randomized clinical trial led by Duke University School of Medicine researcher found that individual cognitive therapy relieved PTSD symptoms better and quicker than group therapy. Nearly half of participants who received one-on-one therapy improved so much they no longer carried a PTSD diagnosis, whereas almost 40 percent of those i...
The University of Utah Health has received a five-year contract renewal from the NIH to test drugs for treating refractory epilepsy, with the goal of identifying novel compounds. The program aims to address unmet medical needs in epilepsy patients and develop new therapies for different types of epilepsy.
Researchers have made significant progress in understanding the genetic diversity of Onchocerca volvulus, the parasite that causes river blindness. The study reveals gene flow between savanna and forest strains, with genes from the savanna strain flowing into the forest strain due to differences in climate and black fly behavior.
Adoption of targeted therapies for chronic lymphocytic leukemia (CLL) could raise treatment costs in the US by almost 600 percent, according to a Massachusetts General Hospital-led research team. The average annual cancer treatment cost has increased from below $10,000 to over $100,000.
A large study found that thiazide diuretics, such as chlorthalidone, are associated with a lower risk of hip and pelvic fractures. The analysis included 22,180 participants followed for up to eight years and reported a 21% lower risk of fractures in the chlorthalidone group compared to other treatments.
A Case Western Reserve University researcher has found that addiction treatment results improved when teens in a residential program stopped smoking. Teens who quit smoking showed lower cravings for alcohol and drugs, similar to their peers who smoked, but with better treatment duration and global functioning.
Researchers investigated resistance to antiangiogenic therapies using animal models, finding inconsistent definitions of treatment failure. The study emphasizes the need for improved methodology to accurately predict alternative strategies that benefit patients.
A five-year project is building on longstanding partnerships with Flint community collaborators to boost stroke awareness and get treatment to more stroke patients. The 'Stroke Ready' program will address barriers to timely evaluation and treatment, helping to reduce the risk of disability by over 30 percent.
Neoadjuvant endocrine therapy is as effective as neoadjuvant chemotherapy for reducing breast tumor size, but with significantly fewer toxic side effects. Aromatase inhibitors were found to be more effective than tamoxifen-like drugs in treating ER-positive breast cancer.
A new clinical trial at UTHealth aims to develop more effective treatment strategies tailored to individual responses for patients overcoming cocaine addiction. The study combines motivational incentives with mindfulness skills training to boost abstinence rates and improve patient outcomes.
Researchers from Duke University have identified two specific receptors, CXCR2 and LTBR, that play a key role in the development of drug-resistant multiple sclerosis. The study found that targeting these receptors may lead to successful treatment for patients who do not respond to interferon-beta treatment.
The journal Drug Delivery and Translational Research published a special issue on ocular drug delivery, highlighting the need for sustainable release of therapeutics to target tissues in the posterior segment. The market opportunity is significant, with the global pharmaceutical market projected to grow to $23 billion by 2018.
Researchers found a combination of immunotherapy options improves overall survival and lowers the risk of life-threatening events in late-stage melanoma patients. PD-1 inhibitors were associated with the lowest risk of life-threatening events, making them a promising first-line therapy option.
A new study reports that soldiers with higher blood pressure before starting prazosin treatment experience better symptom reduction. The study identifies blood pressure as a biomarker that can predict individual response to the medication, potentially leading to personalized medicine approaches for PTSD treatment.
A study has discovered a crucial part of the genetic machinery that switches on the Neuroglobin gene, which is associated with protecting the brain and reducing severity of damage due to stroke and Alzheimer's disease. The research opens up new opportunities for treating AD using gene therapy.
Researchers are investigating DNA sequences from ancient viruses that become active in NF2 tumour cells, and found that certain drugs can block their action and slow down tumour growth. The goal is to develop a new non-invasive drug treatment for people with NF2.
A recent study by Bangor University found that pharmaceutical companies marketing orphan drugs for rare diseases can be up to 15% more profitable than other drug companies. This is due to the lucrative market for these treatments, with some costing as much as £340,000 per patient per year.
The study demonstrates the effectiveness of activity-based probes in detecting early signs of atherosclerosis. By targeting cysteine cathepsins, the probes image activated macrophage populations using optical and PET/CT methods, providing real-time monitoring of disease progression and therapeutic responses.
Researchers used genomic testing and data analysis to predict patient response to psoriasis treatment. The approach identified gene-expression profiles that can be used to forecast treatment success with over 95% accuracy.
PharmaMar announces completion of Phase 3 pivotal study CORAIL with lurbinectedin (PM1183) for platinum-resistant ovarian cancer. The study demonstrates potential therapeutic alternative for patients who relapse after standard treatment. PharmaMar has successfully recruited 443 patients from over 100 hospitals in Europe and the USA.
Limited awareness and physician concerns about patient reactions contribute to the continuation of potentially inappropriate medications (PIMs) at the end of life. Emphasizing the benefits of stopping PIMs, such as reduced pill burden, may increase their discontinuation.
Researchers explore using human pluripotent stem cells to identify cardiotoxicity risks in patients taking chemotherapy agents and other drugs. This approach may boost the number of successful clinical trials for cardiovascular disease treatments.
Researchers aim to create personalized brain signatures for effective PTSD treatment using biomarkers and functional MRI scans. The study will track 160 veterans receiving psychotherapy to evaluate the predictive value of cognitive biomarkers.
CVT-301, an inhaled form of levodopa, is being studied for its potential to restore motor function in people with Parkinson's disease experiencing OFF periods. The Phase 3 clinical program aims to confirm the efficacy and safety profile of CVT-301.
Researchers have developed a new platform using whole animal models that can speed up scientific research and accurately assess the effectiveness of new drugs for neurodegenerative diseases. The platform, which uses roundworms, can analyze thousands of live animals simultaneously and at high speeds.
A new study by the NIH found that even partial steroid treatment can have significant benefits for extremely premature infants. The research showed that infants exposed to partial treatment in the womb had better outcomes than those not exposed, with lower rates of brain and nervous system impairment.
A pooled analysis of 16 prospective multicenter trials found financial difficulties associated with a 35% greater risk of worse global quality-of-life response and a 20% increase in risk of death. Financial burden was present in 26% of patients at baseline, and worsening financial problems during treatment increased mortality risk.
Researchers at the University of Pittsburgh School of Medicine identified a unique 'constrained motion' pattern in which Rad4, a repair protein, scans DNA for structural faults. This discovery could lead to therapies that enhance existing treatments and counter drug-resistance, particularly in cancer.